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Diagnosis and treatment of malignant lymphomas (ML) is very 
often a complicated problem. They are certain major questions to be 
answered: 
1. Are all enlarged lymph nodes a sign for ML? 
2. Where is the primary location of the process - in the medias-
tinum, abdomen and/or certain organ; 
3. What is the exact morphological type (variant); 
4. At what stage is the process diagnosed. 
There are certain therapeutic problems, too and they are con-
nected to the primary disease, as well as to the complications. In the 
following paper we shall describe our 5-year experience in the main-
tenance of ML. One hundred seventy patients were followed - 124 of 
them had non-Hodgkin's lymphoma (NHL) and 46 ones - Hodgkin's 
disease (HD). The data concern the period 1986-1991. Newdiagnos-
tic criteria were introduced. They include: 
1. Diagnostic algorithm for patients with lymphadenomegalia; 
2. Biopsy of lymph nodes (LN) and organs under CT control; 
3. Endoscopic methods; 
4. Cytological, histological and cytochemical investigations of 
biopsy specimens by a qualified persons; 
5. Precise visualization of subdiaphragmal localization of ML by 
echography, CT and lymphography; 
6. Measurement of histamine levels in blood samples as a new 
criterion of biological activity in HD. 
It was found that most complicated are the problems with typ-
ing of centrocytic and lymphoplasmocytic NHL as well as the lym-
phocyte-dominant in HD (400 biopsies of LN were analysed). Clinical 
investigation as well as cytological results led to a correction of the 
diagnosis in 13 patients (7,1%). Fine-needle biopsy under CT control 
was performed in cases of isolated mediastinal, abdominal and organ 
- localization of ML. Four patients with splenomegalia, five with me-
124 
diastinal localization and two with orbital one were diagnosed by this 
method. 
Endoscopy and multilayer biopsy of the gut was performed in 33 
patients with proved ML. Invasion by high grade malignancy lympho-
mas was thus diagnosed. These investigations led to the detection 
of a second neoplastic in 1 patient and a correction of the stage of 
the disease in 5 patients. 
Dynamic ultrasound investigation of abdominal organs and LN 
was performed in 130 patients. Compared to CT in 22 patients and 
direct inferior lymphography in 11 patients shows 96,0% sensitivity 
and 90,0% specificity. 
A new therapeutic mode was introduced: 
1. Hybrid programms (COP-BLAM-IMVp-16, ProMACE, LSA2-L2 
etc.) including also the so-called "salvage" therapy; 
2. Transcatheter method - victory of the problem of pleural ex-
sudates in ML; 
3. Therapeutic regimens during infectious complications; 
4. Mathematical models in the prognosis of ML; 
5. Social readaptation and psychological comfort for patients; 
6. Computer-based mini-information system for the dynamic ob-
servation of patients. 
By the application of these programms full remission was 
achieved in 55,6% of the patients, partial remission in 43,5% of them. 
A bright period of remission was estimated to 24 months (8-36) in the 
average. 
The newtranscatheter method for treatment of pleural exsudates 
was applied in 11 patients. Stable and definitive effect for a period of 
4 to 36 months was achieved in 10 patients. Coping with infectious 
complications was achieved by antibiotic therapy combined with 
microbiological survey, bioproducts and immunomodulators. Thus 
86,0% of inflammations were cured. 
Psychological survey of 54 patients showed different reactions, 
causing a brakedown of social contact. This requires individual ap-
proach, ensuring the social readaptation. Solving these diagnostic 
and therapeutic dilemmas is accomplished by means of a collabora-
tion of a multiprofile medical team. 
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